Starr, P. (2016). Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing. Am Health Drug Benefits.
Dyfyniad Arddull ChicagoStarr, Phoebe. "Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing." Am Health Drug Benefits 2016.
Dyfyniad MLAStarr, Phoebe. "Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing." Am Health Drug Benefits 2016.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.